Urinary alkalinization: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "Pt " to "Patient ") |
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
||
| Line 4: | Line 4: | ||
==Indications== | ==Indications== | ||
*[[Salicylate overdose]] | *[[Salicylate overdose]] | ||
**Recommended for salicylate levels > | **Recommended for salicylate levels >30mg/dl | ||
*Phenobarbital overdose (multidose activated charcoal is superior) | *Phenobarbital overdose (multidose activated charcoal is superior) | ||
*Controversial: | *Controversial: | ||
Revision as of 10:53, 27 July 2016
Background
- Bicarb raises urinary pH which converts weak acids to their ionized form ("ion trap")
Indications
- Salicylate overdose
- Recommended for salicylate levels >30mg/dl
- Phenobarbital overdose (multidose activated charcoal is superior)
- Controversial:
Contraindications
- Patient unable to tolerate volume/sodium load
- Hypokalemia
- Renal insufficiency
Procedure
- Give NaHCO3 1-2 mEq/kg IV bolus OR 3-4 mEq/kg IV infusion over 1hr
- Monitor urinary pH q15-30min until pH is 7.5-8.5
- Sustain alkalinization by either intermittent bolus or continuous bicarbonate infusion
- Monitor serum pH (do not allow to rise above 7.5-7.55)
- Monitor potassium (correct hypokalemia so that alkalinization can continue)
Complications
- Volume overload
- pH shifts
- Hypokalemia